Contents: Oncology 2021

DeepDive Oncology Intro
Introduction

Welcome from the Editor

Click here

Cancer research faces uncertain post COVID landscape
Cancer research faces uncertain post-COVID landscape

There’s a bright future ahead for cancer research in the UK, but only if the government is able to implement a clear plan for funding and development going forward, says The Institute of Cancer Research’s Paul Workman

Click here

ASCO highlights the next generation of cancer therapy
ASCO highlights: the next generation of cancer therapy

We roundup the biggest stories from this year’s conference, giving us a glimpse into the exciting future of oncology

Click here

The pharma world at your fingertips
The pharma world at your fingertips

Daily News from pharmaphorum – insights and analysis on the big trends shaping healthcare and the pharmaceutical industry

Click here

Oncology and a year of COVID lessons for the future
Oncology and a year of COVID: lessons for the future

COVID’s impact on cancer care and oncology research has been devastating, but the pandemic has also opened up opportunities to take learnings and create long-lasting change in research, practice and education, says Lucid’s Frances O’Connor

Click here

Digital tools key to immuno oncology’s future report
Digital tools key to immuno-oncology’s future: report

The explosion in immuno-oncology therapies over the last few years shows no signs of slowing down. As the field becomes more crowded, digital tools may be critical for improving outcomes, says a new whitepaper

Click here

Lessons from the first generation of cell & gene oncology trials
Lessons from the first generation of cell & gene oncology trials

Advances in cell and gene science are paving the way for transformative cancer treatments, but there are still many complexities in delivering clinical trials for these therapies. ICON’s Tamie Joeckel and Brandon Fletcher take us through best-practice approaches to CGT studies

Click here

Oncology R&D: the patient insights we’re still missing, and how to catch up
Oncology R&D: the patient insights we’re still missing, and how to catch up

How pharma, regulators, payers and patient groups can collaborate for deeper and earlier patient engagement

Click here

How digital pathways are changing healthcare
How digital pathways are changing healthcare

Digital health is no longer experimental. Ampersand Health has been working in the space since 2015 and has seen it evolve from a niche approach with limited acceptance to widespread acceptance and deployment across disease areas

Click here

A new investment era for digital start-ups
A new investment era for digital start-ups

Healthware Lab’s Kristin Milburn explores how digital health start-ups can harness the huge potential for the sector in a post-COVID world and the paths they need to take to grow their business

Click here

Enabling healthcare’s digital future
Enabling healthcare’s digital future

Debiopharm Innovation Fund’s Tanja Dowe on investing in digital health start-ups and supporting them on their rollercoaster rides to improve patient outcomes

Click here

Podcast

Listen to discussions of key industry trends with leading pharma figures

Click here

Why pharma shouldn’t forget about sites in a post-COVID world
Why pharma shouldn’t forget about sites in a post-COVID world

The pandemic forced massive changes to oncology sites to ensure patient safety and research continuity – but we must recalibrate and work with sites to understand the value proposition of the technologies and methodologies adopted, says Syneos Health’s Angela Hirst

Click here

Surprise pandemic lessons for pharma
Surprise pandemic lessons for pharma

IQVIA’s John Proctor looks at what the pandemic has taught pharma when it comes to adapting its commercial model

Click here

How hybrid virtual engagement is accelerating oncology communication
How hybrid virtual engagement is accelerating oncology communication

COVID has revolutionised the way pharma engages with healthcare stakeholders – but to be truly successful, digital engagement needs to move away from an overreliance on real-time meetings, say experts from Within3

Click here

DeepDive Oncology Future
Forthcoming issues of Deep Dive

Sign up to receive complimentary editions of the magazine direct to your inbox, including the forthcoming Communications & Commercialisation issue

Click here

DeepDive Oncology Contact
Deep Dive – contact us

How to get in touch with the magazine’s editorial, commercial and design teams

Click here

Video
Share

Your name

Your e-mail

Name receiver

E-mail address receiver

Your message

Send

Share

E-mail

Facebook

Twitter

LinkedIn

Contact

Send